Poland· PL-100450650
Zamidine
A hexamidine product containing hexamidini diisetionas, registered in Poland by Laboratoires Thea. The same ATC class is registered in 8 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Hexamidine is registered in 8 of 19 countries.
Countries holding a registration under ATC S01AX08 (hexamidine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Hexamidine · ATC S01AX08
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Hexamidini diisetionas
- Manufacturer
- Laboratoires Thea
- Country
- Poland (PL)
- ATC code
- S01AX08
- ATC class
- Hexamidine
- Defined daily dose
- 0.1 mg, AT
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909991510107
- gtin05909991510114
- gtin05909991554293
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under S01AX08
Hexamidine, as other registers publish it.
- SwitzerlandDesomedin
- SwitzerlandDesomedin, Augentropfen, LösungBausch & Lomb Swiss AG
- SwitzerlandDesomedin, Augentropfen, LösungBausch & Lomb Swiss AG
- BelgiumDesomedine 0.1 %Bausch & Lomb Pharma
- BelgiumDesomedine 0.1 %Bausch + Lomb Ireland
- United KingdomDesomedine 0.1% eye dropsImported (France)
- BelgiumOphtamedine 1 mg/mlLaboratoires Théa
- DenmarkZamiseptLaboratoires Thea
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/972dd481-f770-4b97-be5c-9feb03c35475 GET /v1/drugs/972dd481-f770-4b97-be5c-9feb03c35475?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krople do oczu, roztwór",
"source": "urpl",
"strength": "1 mg/ml",
"packaging": "05909991510107 ¦ Rp ¦ 149325\n10 poj. 0,6 ml (2 x 5 poj.)\n05909991510114 ¦ Rp ¦ 149326\n5 poj. 0,6 ml\n05909991554293 ¦ Rp ¦ 157992\n1 butelka 10 ml",
"substance": "Hexamidinum 0.58 mg/ml",
"common_name": "Hexamidini diisetionas",
"pl_product_id": "100450650",
"pozwolenie_nr": "27726",
"auth_procedure": "DCP",
"authorisation_validity": "2028-03-21"
}See everything about hexamidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.